Pfizer Recalls One Neurontin Lot; Puerto Rico Plant Still Under Consent Decree
Pfizer is recalling 40,000 bottles of Neurontin (gabapentin) from its Vega Baja, Puerto Rico manufacturing facility after patients reported that capsules of the epilepsy drug were insufficiently filled
You may also be interested in...
Pfizer is launching an internal cost-cutting plan that will rival the synergies achieved by its 2003 acquisition of Pharmacia
Ivax' "at risk" launch of generic gabapentin comes less than two weeks before the anticipated FDA user fee date for Pfizer's Neurontin follow-on drug Lyrica
WARNER-LAMBERT FAJARDO, P.R. PLANT TO BE TAKEN OFF FDA INTEGRITY POLICY SOON, FIRM SAYS; FAILURE TO REPORT DILANTIN TEST FAILURES PROMPTS GUILTY PLEA
Warner-Lambert's Fajardo, P.R. plant will be cleared under FDA's application integrity policy in the near future, the company said following its guilty plea in a case stemming from failure to report stability failures of drugs, some of which were manufactured in the plant.